Who’s Going To Pay For Global Health?
The amazingly swift global response to the SARS outbreak earlier this year demonstrated once and for all that it is possible for countries to join forces and fight epidemics quickly and effectively. So, shouldn’t the same apply to the true pandemics � AIDS, malaria and tuberculosis? Indeed it should � but global strategies to fight these scourges are just now starting to come together.
Seeking a Prescription for Biogenerics
No U.S. laws allow for generic versions of off-patent biotech medicines. Several forces are now working to change that
Why Merck Missed the Mark
S&P’s Herman Saftlas talks about the Street’s reaction to the drug giant’s disappointing earnings report and what the future may hold
Biotech: Teva’s Next Triumph?
The Israeli maker of generics wants a piece of the fast-growing bio-drug market
Gene Therapy Rebuilds Gums
Gene therapy can restore damage caused by severe gum disease, suggest animal studies.
Yali Friedman lives in Washington, DC and is author of Building Biotechnology and other books; founder of DrugPatentWatch; and chief editor of the Journal of Commercial Biotechnology.
Recent Comments